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Abstract 
The Appalachian region of the United States has a high prevalence of diabetes, placing 
residents with diabetes at risk for physical, psychological, social, and financial burdens. 
To compound the issue, primary care providers often do not adhere to the guidelines 
established by the American Diabetes Association (ADA) regarding the recommended 
frequency of testing hemoglobin A1C in patients with diabetes. Lewin’s planned change 
theory guided the project. The purpose of this project was to measure the knowledge of 
the primary care providers before and after an educational intervention covering the ADA 
guidelines for A1C monitoring and testing and to assess compliance with the guideline. 
The 12 volunteer participants were medical doctors, physician assistants and family nurse 
practitioners who served as primary care providers for a rural health clinic. Results of the 
educational presentation and the pre- and posttests indicated that providers improved in 
their knowledge of the ADA guidelines for prevention and management of diabetes. 
Providers identified 9 reasons that patients were not compliant with follow-up for A1C 
monitoring, including lack of provider knowledge of the guidelines, distance to travel to 
the clinic, delayed lab results, forgetting to keep appointments, bad weather, no 
transportation, lost orders for labs, fear that the A1C will be elevated, and fear of having 
more medications added to their treatment plan. This project has the potential to promote 
positive social change by raising awareness among providers of the need for regular 
monitoring of hemoglobin A1C and following the ADA guidelines for the treatment and 
management of diabetes.  In so doing, the project may reduce the complications of 
diabetes for patients in the community.  
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Section 1: Nature of the Project 
Hemoglobin A1C History for Testing and Treatment 
The glycosylated hemoglobin A1C (A1C) test is a blood test that provides 
information about the patient’s average levels of blood glucose over the past 3 months.  
The test is based on the attachment of glucose hemoglobin, with a normal A1C level 
being below 5.7% (Koenig et al, 1976).  Since its discovery, researchers have determined 
that one component, A1C, was observed to be elevated in diabetic patients (Koenig et al., 
1976).  The valuable knowledge of the elevated A1C component has guided researchers 
to the realization it could be used in the treatment or diagnosis of diabetes mellitus (DM).   
In 1984, the additional knowledge of the A1C assay enhanced the use of A1C as 
an effective evaluation tool for the primary care provider (PCP), specifically for the 
evaluation of long-term glucose levels in diabetic patients (Little & Rohlfing, 2013).  The 
challenge of using the A1C as a clinical evaluation tool is the lack of clinical guidelines; 
no central reference, laboratory data, or conclusive and accurate values as a reliable 
reference range available for clinical practice use and implementation (Little & Rohlfing, 
2013).   
The National Institute of Diabetes and Digestive and Kidney Diseases, a division 
of the National Institute of Health, conducted The Diabetes Control and Complications 
Trial from 1983 to 1993 of 1,441 patients with DM.  The Diabetes Control and 
Complications Trial (1983 to 1993) determined the significance of keeping the patient’s 
A1C to a level of 6%, drastically reducing risks of renal, cardiovascular, ophthalmologic, 
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and neurological systems.  In 2013, Epidemiology of Diabetes Interventions and 
Complications continued with a follow up study that tracked the majority of the 
participants in the original study.  The participants who kept their A1C levels between 6 
and 7% had a decrease in the risk of cardiovascular complications (Lenters-Westra et al, 
2013).   
Incorporation of Hemoglobin A1C Into Clinical Practice 
The American Diabetes Association (ADA; 1997) first introduced the A1C 
parameters into their standard of medical care in 1997.  The most up-to-date standard for 
medical practice for A1C testing and DM management was published in 2013and was 
considered to be the gold standard for the best possible patient care (ADA, 2013).  The 
use in clinical practice includes diagnosing, screening, evaluation, and adjustment of diet 
and medications (ADA, 2013).  The A1C test normal range is 5.5% to 7.0% and 
measures a daily average of the previous 90 to 120 days for the amount of glucose that 
comes into contact red blood cell hemoglobin molecules (ADA, 2013).  The testing for 
the A1C in clinical practice is recommended to be done every 6 months (semiannually) 
for patients who are stable < 7.0%, as per ADA guideline suggestions; if ≥ 7%, the A1C 
should be done every 3 months (quarterly) (ADA, 2013).   
Significance of Diabetes in the United States 
Diabetes is the seventh leading cause of death in the United States, according to 
the Centers for Disease Control and Prevention (CDC).  In people with diabetes, the 
leading cause of death is contributed to cardiovascular disease; it is estimated that 68% of 
diabetics die of stroke or heart disease in the United States (CDC, 2011).  Overall, the 
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diabetic population death risk is double of people without having diabetes (Centers for 
Disease Control and Prevention [CDC], 2011).  It is estimated that 230,000 Americans 
die each year from complications of diabetes, according to the National Institute of 
Diabetes and Digestive and Kidney Diseases (U.S. Department of Health and Human 
Services, National Institutes of Health, National Institute of Diabetes, and Digestive and 
Kidney Diseases, 2011).   
In 2011, there were approximately 26 million people diagnosed with diabetes in 
the United States (CDC, 2011).  The estimated total health care cost of diabetes is $174 
billion annually; broken down, the direct medical cost including treatment supplies, 
medical care, and hospitalizations account for an estimate of $116 billion (CDC, 2011).  
The indirect covers cost such as time lost from work, disability payments, and premature 
death is estimated to be about $58 billion (CDC, 2011).  DM can lead to complications of 
cardiovascular disease, hypertension, stroke, kidney disease, amputations, and blindness 
(Diabetes Basics, 2013).   
Significance of Diabetes in West Virginia 
The Appalachian Region became as an entity by the federal government in 1969.  
It covers about 110,000 square miles in the states of Maryland, Virginia, West Virginia, 
Kentucky, Tennessee, North and South Carolina, and Georgia.  The population of the 
Appalachian Mountain Chain is approximately 24.8 million people, with 42% of the 
population living in rural areas, including the entire state of West Virginia (WV) (The 
Appalachian Community, 2012).  Geographically isolated throughout much of their 
history, the people of Appalachia are thought to have retained cultural traditions of the 
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early 19th century (The Appalachian Community, 2012).  Lagging behind the United 
States, Appalachia continues to fall behind on social and economic indicators (The 
Appalachian Community, 2012).  Thus, long-standing poverty and accompanying 
stresses continue to threaten the health of the people living in this region (The 
Appalachian Community, 2012).   
Diseases and comorbid conditions such as diabetes, stroke, cardiac, cancer, and 
other associated health conditions and risks are frequently as high for many living in 
Appalachia as for other groups considered to be of national minority (The Appalachian 
Community, 2012).  Recent population statistics for WV in November 2013 show that 
about 1 in 8 adults in WV have diabetes (The Appalachian Community, 2012).  The most 
recent statistics for WV show the state to have between the second and fourth highest 
population of people to have diabetes in the country (Goss, 2013).   
WV is federally designated as a Primary Care Health Professional Shortage Area 
(U.S. Department of Health and Human Services, 2013).  More specifically, in rural WV, 
the problem of inadequate diabetes management is worsened by the absence of 
endocrinologists to provide specialized care to the diabetic patients in those rural areas 
(U.S. Department of Health and Human Services, 2013).  The nearest endocrinologist 
specialist is sometimes two hours away.  There are many people who do not own a 
vehicle or have reliable transportation to drive the required distance to the 
endocrinologist for diabetes monitoring or management (U.S. Department of Health and 
Human Services, 2013).  Thus, it is imperative for providers to follow recommended 
guidelines in order to maximize patient outcomes. 
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Diabetes has been monitored in WV through surveillance and statistic centers.  
Through this monitoring, facts about health equity and the social determinants of health 
in rural areas of WV were discovered.  The reports through the Department of Health and 
Human Resources revealed that people with diabetes make less money and have less 
education.  Counties with higher diabetes prevalence, also had lower income levels and 
more people with diabetes who were unable to work.   There is a higher prevalence of 
people with diabetes who report they have an impairment that limits their activities, and 
people with diabetes have higher levels of life dissatisfaction (Stohr, 2012).  Northcentral 
WV, during the years 2006 to 2010, had a low prevalence of DM at 7.9%.  Higher levels 
of diabetes prevalence in the same report was in southern WV at 17.7% (Stohr, 2012).   
In 2010, Novo Nordisck Pharmtech comissioned a comparison to be made for the 
years of 2010, 2015, and 2025 with statistics and projected percentages for people with 
diabetes in WV.  In 2010, the approximate number of people living with diabetes was 
268,554, with a prevalence of 14.68% of the state population of people living with 
diagnosed or undiagnosed diabetes (Changing Diabetes Barometer, 2014).  In 2015, the 
approximate projected number of people living with diabetes was expected to be 290,113, 
with a projected prevalence of 15.92% of people living with diabetes(Changing Diabetes 
Barometer, 2014).   
By 2025, the projected number of the people living with diabetes is expected to be 
314,864, with a projected prevalence of 17.82% of people to be living with diabetes in 
WV (Changing Diabetes Barometer, 2014).  According to Novo Nordisck Pharmtech’s 
current and projected statistics, it is important to keep track of the population who is at 
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risk or who have diabetes, the kinds of management provided, such as monitoring the 
frequency of testing the A1C, and the results that are to be achieved.   
Facts about the Appalachian rural clinics include the diagnosis prevalence rates 
among adults.  According to the CDC (2011), in rural WV, the prevalence rate was in the 
high range (12.1–21.6%).  According to the Institute for Alternative Futures, the 
estimated prevalence rates for 2015 was approximately 194,400 with diagnosed diabetes, 
another 95,700 with Type 2 diabetes that remained undiagnosed, and an additional 
464,300 who had prediabetes (Changing Diabetes Barometer, 2014).   
 Problem Statement 
Despite the standards of practice, diabetes continues to be a concern in the United 
States.  Over 28 million people are being treated for the disease and treatment, costing 
245 billion per year (Statistics About Diabetes, 2014).  The use of ADA clinical practice 
standards and guidelines by the PCP can enhance the quality of care and patient outcomes 
for individuals with diabetes.  However, the PCP practice problem can be a result of self-
efficacy and lack of confidence in ability, leading to clinical inertia (Shaefer, 2006).   
Purpose Statement 
 The purpose of the Doctor of Nursing Practice (DNP) project staff education is to 
measure the knowledge of PCPs from an educational intervention regarding the 
recommended ADA guidelines for A1C patient monitoring and testing.     
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Project Objectives 
The objective of this DNP staff education project is to increase the knowledge of 
the ADA guidelines for A1C patient monitoring and testing among PCP in Appalachian 
rural clinics.   
Project Question 
Is there a difference in knowledge following an educational intervention regarding 
the ADA guidelines for A1C patient monitoring and testing among PCP in Appalachian 
rural clinics?   
Evidence of Problem 
The specific identified practice problem is the frequency of testing of the A1C in 
the Appalachian rural clinics.  According to the ADA guidelines, routine monitoring of 
glycemic control using A1C by providers in clinic practice is often not completed during 
routine office visits (Egbunike & Gerald, 2013).  Eighty percent of patients in the first 
year after diagnosis with diabetes do not have testing for A1C measurements during their 
office visits (Egbunike & Gerald, 2013).   
Strategies and tools such as electronic chart provider reminders for testing of 
A1Cs are underused in the rural clinics.  In order to provide safe, effective, and quality 
care to the patients in the Appalachian rural clinics for prevention, diagnosing, and 
monitoring of diabetes, it is imperative to have tools and strategies in place to educate, 
remind, and ensure the PCPs follow the ADA guidelines.   
The PCP in the Appalachian rural clinics should adhere to the recommended 
frequency for doing A1C testing, according to the ADA guidelines for diagnosing and 
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management of Type 2 diabetes.  Monitoring by obtaining the A1C at regular intervals in 
the rural clinic helps to provide the diabetic patient with safe and effective care that has 
optimal outcomes  (Egbunike & Gerald, 2013)  However, some PCPs do not adhere to or 
use the recommended evidence-based practice (EBP) guidelines as outlined by the ADA 
for the testing and frequency intervals of obtaining the A1C measurements (Egbunike & 
Gerald, 2013).   
Optimal outcomes of quality care in the DM patient require the timely testing of 
A1C in order to prevent poor diabetes management or control.  Patients with poor or 
uncontrolled DM are at increased risk for organ damage and other complications, 
including macrovascular and microvascular complications (Egbunike & Gerald, 2013).  
DM patients with the macrovascular and microvascular complications are at a greater risk 
for glaucoma, neuropathy pain, peripheral amputations, and nonhealing wounds 
(Egbunike & Gerard, 2013).   
The standardization of the A1C measurements in recent years has been endorsed 
by the World Health Organization as a diagnostic criterion for the diagnosing and 
management of diabetes.  In 2009, the ADA supported and recommended the use of 
A1C, along with many other major professional diabetes associations.  The World Health 
Organization and ADA have recognized the advantages of using the A1C since no fasting 
is required by the patients with less measurement variability than levels of plasma 
glucose (Smith, 2012).   
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Implications for Social Change 
This DNP proposal is significant for social change because EPB literature has confirmed 
that diabetes is a health problem for people in rural WV.  Appalachian rural clinic PCPs 
currently do not have standard tools in place to monitor the frequency of A1C testing for 
the patient at risk or who already has diabetes Type 2.  The ADA guideline literature has 
indicated that following the clinical practice guidelines for the frequency of A1C testing 
helps to provide the diabetic patient with safe and effective care with optimal outcomes.  
The social change will improve and impact the individuals in the Appalachian patient 
population by helping to control diabetes by the PCP use of the ADA A1C clinical 
practice guidelines. 
Definition of Key Terms 
The definition of key terms that are often used in duplication and throughout this 
study include the following: 
American Diabetes Association (ADA): A professional association whose goal is 
to educate and help those who are affected by the consequences of diabetes, provides 
objectives and credible information about diabetes, and funds research to manage, 
prevent, cure, and deliver services to communities (ADA, 2013).   
Appalachian region: The Appalachian Mountain Chain and rural areas, including 
the entire state of West Virginia (The Appalachian Community, 2012).   
Diabetes mellitus (DM) or Diabetes: A condition (hyperglycemia) that results 
because the body is no longer able to use blood glucose for energy.  Type 2 diabetes 
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occurs when the pancreas is unable to use the insulin correctly or not enough insulin is 
made (ADA, 2013).   
Glycosylated hemoglobin A1C (A1C): A lab test that measures the previous 90 to 
120-day (2 to 3 months) average of the glucose amount that has contact or sticks with the 
red blood cell hemoglobin molecules (ADA, 2013).    
Assumptions and Limitations 
 In this project, there are more limitations than assumptions.  I assumed that 
providers want to do what is right or is considered to be best for the patients they care for 
in clinical practice (see Shaefer, 2006).  Another assumption is that educating the 
providers will change practice, and changing practice will improve health.  I also 
assumed that the patient wishes to become involved in his/her care for the improvement 
of his or her health. 
Limitations for the use of clinical practice guidelines that can occur in the rural 
clinics are that the provider incorrectly ordered the A1C test.  Overuse of testing and 
resources adds additional unnecessary cost to the patient and health care system.  The 
standards are patients with A1C values that were ≤ 7%; according to the ADA (2013) 
clinical practice guidelines, the A1C does not need to be ordered again for a year.     
If the A1C testing is done more often than necessary, it is evident that PCPs need 
support in the learning process and continued education.  The geographical area where 
the rural clinic was located can be a limitation to the frequency and PCP adherence to 
following the EBP ADA guidelines.  The area has harsh weather during the winter 
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season; snow, cold, and ice can be a reason the patient may not be able to make it to their 
provider for scheduled appointments or have A1C testing completed in a timely manner.   
Lastly, a limitation that could occur in the rural PCP is the tracking of A1C 
testing.  The rural clinics have electronic health records (EHR); however, not all 
documents are typed in a timely manner.  The progress note is scanned into the EHR 
directly after the provider visit.  However, the provider has to take the time later to get it 
typed; there are times because of the increase in patient load that the notes do not get 
typed for several weeks.  Therefore, the tracking system cannot be used correctly to 
monitor the frequency of A1C testing.   
Summary 
In summary, the Appalachian rural clinic PCPs currently do not have standard 
tools in place to monitor the frequency of A1C testing for patients at risk or who already 
have dabetes Type 2.  Testing for the A1C by PCPs in clinical practice is often not 
completed during the patients routine office visits.  The ADA and other EBP literature 
has indicated that following the clinical practice guidelines for the frequency of A1C 
testing helps to provide the diabetic patient with safe and effective care with optimal 
outcomes.  Diabetes is an issue in the rural community and in WV.  Having adequate 
healthcare and diabetic management is critical to providing high-quality diabetes care to 
the Appalachian  rural population.   
The practice problem for the DNP staff education project is that some PCPs need 
to be made aware and knowledge and understanding about the ADA guidelines. The PCP 
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practice problems can be a result of self-efficacy and lack of confidence in ability, 
leading to clinical inertia (Shaefer, 2006).    
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Section 2: Background and Context 
Introduction 
I conducted a literature review and comprehensive search to obtain EBP literature 
and studies related to the monitoring of the provider frequency for A1C testing and 
frequency in the Appalachian rural clinics (see Burns & Grove, 2009).  The literature 
review was also necessary in the search for clinical practice ADA guidelines, the self-
efficacy and ADA guideline agreement, and the ADA clinical practice guideline 
adoption. In this section, I also cover the theoretical framework, and EBP model using 
scholarly data that provide a foundation for the development of the plan for patient 
management of DM.   
The search strategy included a systematic approach consisting of a detailed 
search, including Publisher Medline, Nursing & Applied Health Sciences, Cumulative 
Index to Nursing and Allied Health, Ovid Nursing Journals Full Text, and Medical 
Literature Analysis and Retrieval System Online.  Other online searches were conducted 
through Mozilla Firefox Google, where I found EBP material, data, and information such 
as but not limited to the ADA, Healthy People 2020, United States National Library of 
Medicine, and WV Department of Health and Human Resources.   
I focused on EBP guidelines and studies written in the English language from 
early 2000 to 2014, with a small number of articles selected in the search process being 
prior to the year 2000 because no recent information and literature were comparable.  The 
search produced 496 articles, dissertations, meta-analyses, systematic reviews, peer-
reviewed articles, comparison studies, randomized control trials, cross-sectional analyses, 
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experimental research studies, and journal articles with guidelines and models.  A final 
number of research articles used in the DNP pilot project was 16.  The search words used 
for the database search were glycosylated hemoglobin A1C, Hgb A1C, A1C, diabetes 
mellitus, diabetes, rural diabetes care, diabetes outcomes, and frequency of A1C testing.     
Literature Review 
ADA Guideline Awareness and Adherence 
Physician and provider adherence are crucial in interpreting recommendations 
into improved patient outcomes (Cabana et al, 1999).  The National Clearinghouse of 
Guidelines provides sources to assist health care providers with guidelines on many 
clinical issues.  The EBP database is available to the public for free (U.S. Department of 
Health and Human Services AHRQ, 2014).   
The patients where adherence was followed according to the ADA guidelines for 
the frequency of monitoring the A1C in rural PCP had better A1C diabetes control that 
those where the ADA guidelines were not followed (Parcero, Yaeger & Bienkowski, 
2011).  This provides strong empirical support in adherence of following the A1C 
frequency to the ADA guideline (Parcero et al, 2011).  The monitoring and measurement 
of glycemic control are considered a basis for management for patients with DM.  Having 
the A1C lab results at the point of care during patient visits results in an increase in the 
use in therapy and an improvement in the patient’s glycemic control (Neumiller et al., 
2010).   
Interventions by physicians in clinical practice including feedback about glycemic 
control monitoring of A1C has led to improved diabetic patient care in Medicare 
15 
 
 
beneficiaries (McClellan, et al., 2003).  In general, patients in rural communities need 
greater attention to diabetes care.  The ADA recommendations are for the A1C testing to 
be completed every 3 months.  In this study, I focused on physicians, physician assistants, 
and nurse practitioners, finding that PCPs are slow to accept standards of care for 
diabetes care and management (Glasser, Peters, Warner, Burkholder, Sharp, McGee, 
2010).  In 2011, Parcero, Neumiller, McClellan, and Glasser concluded that the lack of 
awareness or knowledge about the guidelines and its objectives has resulted in low 
adherence to the frequency of A1C testing.       
ADA Guideline Agreement and Self-Efficacy 
Use of the ADA guidelines by the PCP can help to increase glycemic control; by 
doing this, the incidence of comorbidities related to DM Type 2 is reduced (Schaefer, 
2006).  A PCP’s lack of self-efficacy leads to clinical inertia. Clinical inertia is described 
as a provider's unwillingness or inability to intensify medication treatment in patients 
whose glycemic control is nontherapeutic (Schaefer, 2006).   
The physician or provider finds patient poor adherence to be because of having 
low self-efficacy.  Low adherence is due to the lack of preparation or lack of confidence 
in ability.  Researchers have suggested that the barrier is associated with counseling and 
preventive health education, suggesting that poor self-efficacy may be a common barrier 
to adherence for EBP health care and management guidelines (Cabana et al., 1999).  Self-
efficacy is the confidence and belief that a person can perform a behavior; it also impacts 
whether the behavior will be started and continued in spite of poor outcomes (Cabana et 
al., 1999).  A low self-efficacy that is due to a lack clinical inertia is considered to be a 
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problem that occurs commonly by providers when managing illnesses that did not present 
in a systematic way (Cabana et al., 1999).  Clinical inertia is caused by the recognition of 
a problem, not necessarily by the failure to act on the problem. Some providers may be 
quick to lay the blame on the patient’s noncompliance; however, researchers have shown 
that clinical inertia is the problem of the physician and provider delivery system, along 
with the health care system that did not take appropriate action for the benefit of that 
patient(Cabana et al., 1999). Clinical inertia can be applied to silent chronic diseases such 
as diabetes, hypertension, and hyperlipidemia.   
In diabetes, some providers have failed to screen, diagnose, manage, or treat a 
patient with diabetes at an acceptable A1C level of < 7%. The failure has been in spite of 
the 2011 CDC, current data that show that diabetes is an epidemic expanding problem in 
the United States.  Society is well aware of DM with print media, such as popular 
magazines and television advertisements concerning DM (Shafer, 2006).   
Clinical inertia is directly recognized as a lack of self-efficacy because of the 
provider having an attitude barrier.  The provider having a casual awareness of the 
guideline recommendations does not guarantee the familiarity of A1C guidelines and the 
actual ability to use them correctly (Cabana et al., 1999).  The providers in rural PCPs 
with adherence to the ADA guidelines for frequency of monitoring hemoglobin A1C had 
patients with better glycemic control of diabetes than those who did not; therefore, this 
provides to be strong empirical support for the guidelines (Parcero et al, 2011).  In order 
to end clinical inertia, the PCP barrier of awareness requires both guideline knowledge 
and a change in provider behavior (Vigersky, 2011).   
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ADA Guideline Adoption 
Full adoption of the clinical guidelines requires that the PCPs agree with the 
guidelines (Massey, Appel, Buchanan, Cherrington, 2010).  As part of this adoption of 
the EBP ADA guideline, the PCP should acknowledge the A1C as the standard method 
of monitoring diabetes, thus increasing the patient's glycemic control (Parcero, 2011).  
The PCP requires both guideline knowledge and a change in provider behavior.  PCPs 
use the A1C testing and monitoring to educate the patient, make changes in the patient's 
diet, provide recommendations for exercise, and adjust the medication regimen 
(Vigersky, 2011).   
The PCPs that understand the ADA clinical practice guidelines are likely to be 
involved in different approaches to reach their patient population in the community, such 
EBP ADA guidelines regarding the frequency of A1C monitoring and testing in primary 
care setting (ADA, 2013).  In addition, there is an increase in the patient’s mortality and 
morbidity with poor control of glycemic levels (ADA, 2013). 
Theoretical Framework/ Evidence-Based Practice Model 
The DNP Essential I of nursing practice examines nursing theory and science that 
focus on the concepts to strengthen and support the DNP practice (Zaccagnini & White, 
2011).  EBP models, and theoretical framework are used by the DNP to help in the 
organization and integration of nursing knowledge, practice, and science.  Theories and 
models can also offer a systematic way to clarify the parameters of nursing practice to 
benefit the DNP project to improve compliance of A1C testing following the EBP 
clinical ADA guidelines (Zaccagnini & White, 2011).  The project requires a 
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strengthening in clinical practice by the health care PCP in the rural clinic.  To help in the 
change process of clinical practice using the ADA clinical practice guidelines will be the 
use of  Lewin’s planned change theory and the plan-do-study-act (PDSA) improvement 
model  
Theoretical Framework 
Today’s healthcare is in a constant state of change.  With change, come feelings 
of anxiety, uncertainty, and upheaval (McEwen & Wills, 2011).  The theory applies to the 
DNP project for a smooth transition of the change in clinical practice for health 
promotion and disease prevention is the Lewin’s planned change theory.  A force of 
change according to Lewin is the driving force (McEwen & Wills, 2011).  The DNP can 
be part of that driving force to help in the disease prevention and management of 
diabetes; thus, improving the overall outcome of the patient mortality and morbidity in a 
rural clinic.  To be successful in the planned changed are unfreezing, movement, and 
refreezing.  (McEwen & Wills, 2011).   
There are three phases of Lewin’s planned change theory for the rural clinic: 
1.  Unfreezing – involves meeting with the primary care providers to discuss a 
need for the change in clinical practice to follow the ADA guidelines for 
frequency of A1C testing in the diabetic patient to alleviate any stress or 
uneasiness about the process.   
2.  Movement – Prior to the initiation of change, research of diabetic patient 
population, education materials, ADA guidelines for use by for the primary 
care providers in the rural clinic, and feasibility of the change in practice.   
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3.  Refreezing – Stabilization occurs, and the planned integration into primary 
care provider has initiated and uses the ADA clinical practice guidelines as 
part of their daily practice for monitoring of the A1C to improve glycemic 
control in the diabetic patienets in the rural clinic. 
(McEwen & Wills, 2011) 
Evidence-Based Practice Model 
Along with the Lewin’s planned change theory; PDSA improvement model will 
be used by the DNP in the clinical practice change process for a smooth transition of all 
involved.  A model that can be utilized in the rural clinic practice setting is the PDSA 
model for improvement.  The PDSA model in particular was chosen because it can be 
simply used as a guide by the DNP to incorporate a systematic process for change to EBP 
(Pipe, 2007).  The model’s focus is for change to the EBP by using the PDSA (White & 
Dudley-Brown, 2012).   
The PDSA steps are as follows:  Plan - the change to be implemented or tested 
involves gathering baseline data.  This stage is to test for quality improvement.  Do - 
carry out the project on a reduced scale and change the processes as problems occur. At 
this stage, documentation of the process occurs along with the integration of data 
analysis.  Study - set aside sufficient time to analyze the data.  Act - analyze the data, 
plan revision, and restart the PDSA cycle (Institute for Healthcare Improvement, 2011).   
Plan-Do-Study-Act Method 
The appropriate method for implementation is the use of the PDSA method for 
the project in the rural clinic health care setting (Institute for Healthcare Improvement, 
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2011).  The PDSA cycle identifies specific measures of change; then, test change in the 
actual work setting (planning, trying, observing, and acting) on the actual results about 
what is learned (Institute for Healthcare Improvement, 2011).  The aim is to refine the 
improvement of the project by using the PDSA cycle.  This is accomplished by 
advancing through the PDSA cycles numerous times eventually having the ability to 
apply the implementation of change on a broader scale basis throughout a larger 
healthcare system (Institute for Healthcare Improvement, 2011).    
Summary 
Change is important to improve patient outcomes in the current healthcare system 
(Hykas & Harvey, 2010).  Coming up with new solutions by using research and EBP, 
then integrating the new knowledge into clinical practice is part of the leadership role 
used by the DNP nurse (Hykas & Harvey, 2010).  The comprehensive literature search 
completed for the provider A1C frequency testing in the rural clinic setting  program 
design came from different sources such as the Walden University library and other 
reliable online internet sources.  EBP used for the DNP project development came from 
the ADA clinical practice guidelines.  The EBP theoretical framework and model 
included the Lewin’s planned change theory and thepPlan-do-study-act improvement 
model and is applied to the EBP DNP project transition of the change in the Appalachian 
rural clinics.   
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Section 3: Collection and Analysis of Evidence 
Introduction 
 The purpose of this section is to explain an improvement plan designed for a 
future full scale long term organizational process and evaluation plan.  I discuss the 
project design and methods, the setting and participants with permission and protection, 
and an overview of the project design and evaluation plan using the PDSA.  The DNP 
project is divided into five stages that represent portions of the PDSA cycle for future use 
at the Appalachian clinic. 
Step 1 is plan. I assumed a leadership role in this project by educating the PCP 
through a Power Point presentation (Appendix A) on the importance of obtaining the 
A1C in the Appalachian rural clinics.  I also reviewed all the objectives of the DNP 
project with the participants.  I trained the head family nurse practitioner (FNP) on how 
to follow up with the administration of the pretest (Appendix B) to the providers; if 
needed, the head FNP will review the material again in the educational Power Point 
presentation (Appendix A).   
Step 2 is do. The trained head FNP followed up with each of the providers 
participating to see if objectives were followed.  If needed, there was remediation with a 
review of the educational Power Point (Appendix A) with objectives and a review of 
clinical inertia.   
Step 3 is study. The head FNP administered the posttest (Appendix B) with the 
participating providers, collected all the data, analyzed the qualitative data, identified the 
22 
 
 
common themes, and prepared the final report that will be completed semiannually by the 
head provider in the Appalachian rural clinics. 
Step 5 is act. Issued the final report to the members of the Appalachian rural clinic 
participants, members, and the administration.  To keep me informed and involved, a 
report of the final data and outcome will be presented either via phone, personal visit, or 
e-mail.   
Design of Staff Education 
The purpose of the project was to increase the knowledge of the PCPs regarding 
the ADA clinical practice guidelines following an educational intervention and to assess 
compliance of use of the guidelines among providers.  Specifically, each provider took a 
prereview test (Appendix B) to determine the level of baseline knowledge, behavioral 
barriers, and self-efficacy using the ADA clinical practice guidelines for A1C 
monitoring.  Then, each provider viewed the Power Point presentation (Appendix A) to 
introduce the ADA clinical practice guidelines for A1C monitoring.  After the review, the 
providers were asked to complete a posttest (Appendix B) to determine if an increase in 
knowledge has occurred.   
Project Setting and Participants’ Staff Education  
The setting was an Appalachian rural clinic privately owned by a medical doctor 
in family practice in rural WV.  The population and sample in the study included six 
medical doctors, two doctors of osteopathic medicine, 13 master’s level prepared FNPs, 
and 11 master’s level prepared physician assistants (PA), for a total of 32 potential 
participants.  Permission was granted to access the EHR of each PCP that agreed to 
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participate in the DNP project.  As providers are hired, the head FNP will repeat the 
process and steps of the PDSA cycle, adding to the semiannual report. 
The Health Insurance Portability and Accountability Act law states that all patient 
data are protected; therefore, no patient data will be divulged before, during, or after the 
DNP project concerning the adherence about the frequency of A1C testing and 
monitoring of the diabetic patients in the Appalachian rural clinic (U.S. Department of 
Health and Human Services, 2003).   
Data Collection of Staff Education  
In order to determine an increase in knowledge among the providers, each 
provider completed a pencil-paper pre- and post-test survey (Appendix B) with the use of 
a personalized identifier.  The pre- and post-test surveys contained nine questions, with 
Questions 1 to 4 related to knowledge of the ADA A1C National Guidelines.  Questions 
5 to 9 addressed PCP thoughts about the usefulness of following the ADA clinical 
practice guidelines in ordering. The pre- and post-test surveys were identical in nature, 
and no identifiable information was collected.   
Data Analysis of Staff Education  
Data from both the pre- and post-test surveys and from the retrospective chart 
review were entered into an Excel spreadsheet.  The data from the pre- and post-test 
surveys were analyzed using descriptive and inferential statistics to determine if there 
was a difference in the number of questions answered correctly in the pre- and post-test 
surveys.   
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Budget and Timeline 
The budget and financial analysis for improving provider A1C testing frequency 
adherence to the ADA clinical practice guidelines did not require many resources/ much 
funding to initiate the DNP project.  The rural clinic owner covered the cost of resources 
for the pilot project.  The potential PCP participants have already declined an 
honorarium.   
For the proposed practice change to be effective and successful in the 
Appalachian rural clinic, there must be materials to present to the providers about A1C 
testing frequency and the guidelines, space for the meeting, paper to print off the 
education action plan booklet for the providers, use of a scanner and copier, and 
employee time.  The staff in the rural clinic were provided lunch with an in-kind clinic 
donation from the owner on the provider informative training days.  The direct cost for 
the DNP project ADA guideline on A1C frequency and testing training days for the 
providers totaled $2,931.96. 
The timeline for the DNP project was created to follow the progression of the 
DNP project from beginning to end.  The prevention and control of DM is accomplished 
when the PCP adheres to the ADA clinical practice guidelines for the frequency of A1C 
testing, thus increasing the quality of life of the patient population.  Success of the project 
depended on feedback from providers.  The minimal startup cost of the project along with 
the funding assistance of the clinic administrator/owner equals saved lives and the cost to 
the target group.   
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Summary 
 The DNP project is critical for sustainability as it studies one of the most 
profound diseases in our nation today.  Designing and managing problems of this 
magnitude are important not only for this underserved health population but for so many 
others who are still not identified or being served adequately (Smith, 2011).  Monitoring 
of the A1C levels helps to reduce the incidence of health care costs and comorbidities in 
the Appalachian rural clinic patient population.  The purpose of this project was the 
development of quality improvement use of ADA clinical practice guidelines with a 
focus on the frequency of A1C testing for the implementation by the provider.  The 
practice change based on EBP can be successful in the rural clinic, particularly if active 
collaboration occurs with all parties involved working together in the direction of the 
same common goal.   
IRB:  07-12-18-0408605 
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 Section 4: Findings and Recommendations 
Introduction 
 The purpose of this DNP project was to provide staff education and evaluate the 
measure of knowledge of the PCP in an Appalachian rural clinic located in WV.  The 
DNP project topic and questions regarded the recommended ADA guidelines for A1C.  
PCP education was of importance for a smooth transition of change in a clinical practice 
setting among the PCP for health promotion and disease prevention of DM.  A force of 
change, according to Lewin in 2011, was the driving force to improve the overall 
outcome of the patient mortality and morbidity in an Appalachian rural clinic in WV by 
educating the PCP on the ADA guidelines for A1C monitoring and testing.  The DNP 
objective for the staff education was to increase the knowledge of the ADA guidelines for 
A1C monitoring and testing among PCP.   
 Optimal outcomes of quality care in the DM patient require the timely testing of 
A1C to prevent poor diabetic management or control.  The patient with poor or 
uncontrolled DM is at an increased risk for organ damage. DM patients are at a greater 
risk, leading to glaucoma, neuropathy pain, peripheral amputations, and nonhealing 
wounds.  Following the ADA guidelines, routine monitoring of glycemic control using 
A1C by providers in clinic practice is often not completed during routine office visits 
(Egbunike & Gerard, 2013) .  Eighty percent of patients in the first year do not have 
testing for A1C measurements (Egbunike & Gerard, 2013).  Therefore, the patient 
population can be impacted by PCP’s use of the tools provided for achieving goals that 
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addressed an increase in their knowledge of the ADA guidelines or frequency of A1C 
monitoring and testing.   
 Tools used for educating the PCP were a self-developed Power Point presentation 
on the importance of obtaining the A1C and a pre/post survey.  A presurvey and 
postsurvey with the participating providers determined the level of baseline knowledge, 
behavioral barriers, and self-efficacy using the ADA guidelines for A1C monitoring.  The 
pre- and post- survey asked nine questions identical in nature; Questions 1 to 4 related to 
knowledge of the ADA guidelines, and Questions 5 to 9 examined the PCP’s thoughts 
about the usefulness of the clinical ADA guidelines.  The rating scale for Questions 1 to 9 
included highly disagree, somewhat disagree, neither agree nor disagree, somewhat 
agree, and highly agree.  
 Each PCP participant took a presurvey to determine the baseline level of 
knowledge using the ADA guidelines for A1C monitoring and testing.  The PCP then 
viewed the A1C education component of A1C according to the ADA practice guidelines 
and then was given the opportunity to ask questions to make sure the goals were 
understood.  Lastly, at the conclusion of the Power Point, each PCP completed the 
postsurvey, determining if there was an increase in PCP awareness and understanding of 
the ADA guidelines for A1C testing.   
Discussion of Findings 
Demographics 
 The PCP participants in the Appalachian rural clinic comprised of medical 
doctors, doctors of osteopathic medicine, physician assistants, and FNPs, for a total of 32 
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potential sample pool PCP participants.  Out of the 32 volunteers to participate in the 
DNP project, a total of 12 pre/post surveys were completed and returned.  The total PCP 
completion rate was 38%.   
A review of the surveys, pre/post survey Questions 1 to 4 pertained to the 
knowledge of the ADA guidelines A1C testing frequency; Questions 5 to 9 indicated the 
PCP attitude about using the guidelines.  For Question 1, 92% of the PCP participants 
presurvey answered the rating of highly agree with being familiar with the ADA 
guidelines pertaining to the frequency of A1C monitoring and testing in the patients with 
diabetes; however, in the postsurvey, they answered 100% highly agree on the same 
question.  For Question 2, 67% of the PCP participants answered highly agree on the 
presurvey for offering safe, effective, quality care; on the postsurvey of that same 
question, there was a rating of 100% highly agree.   
In the last question of the pre/post surveys, each PCP was given the chance to 
identify and describe any barriers that existed in their clinical practice to measure A1C in 
the diabetic patients according to the ADA guidelines.  The behaviors reported and 
identified that hindered their patients to have the A1C included the following: 
1.  Lack of provider or nursing knowledge of guidelines.   
2.  Distance the patient has to travel to be seen (rural setting).   
3.  Delayed lab results (requiring extra follow-up appointment for patient). 
4.  Patient’s failure to keep appointment due to forgetfulness.   
5.  Bad weather or lack of transportation cause canceled appointments. 
6.  Patients losing their lab order after A1C is ordered (lab location barrier). 
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7.  Patient is noncompliant or patient knows their A1C will be elevated. 
8.  Patient simply does not want to come to appointment because it might result in 
added medications or a change in lifestyle.   
All of the 12 PCPs in the Appalachian rural clinic who responded and returned the 
post surveys for education and knowledge of A1C monitoring agreed that they are now 
more aware of their ordering and monitoring practices.  Responses to the Appalachian 
rural clinic PCP presurvey is shown in Appendix C.  PCP postsurvey results are found in 
Appendix D.  Also, Appendix E:  Pie chart for comparison of presurvey of total 
responses and Appendix F:  Pie chart for comparison of postsurvey of total responses 
Implications 
Implications on Practice, Future Research, and Social Change 
 Evidence-based literature has confirmed that DM is a health problem for the 
patient population in the Appalachian region; therefore, PCP education is of significant 
importance.  ADA guideline literature indicated that following the ADA guidelines in 
clinical practice for the frequency of A1C monitoring helped provide the PCP with 
knowledge needed for diabetic patients.  Education and training need to be continued 
with new PCP hires for the success of future research.  A potential positive social change 
is that the patient’s quality of life can increase by decreasing mortality and morbidity of 
potential negative outcomes of multisystem complications that could occur as a result of 
having DM.   
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Limitations 
 The PCP education survey pre/post evaluations were limited due to less than 
expected PCP participation of postsurvey completion.  The initial number of PCP 
volunteer participation in the Appalachian rural clinic in the education was 32.  Various 
factors were reported that prevented a greater PCP participation, including previous 
obligations, meetings, illness, vacations, and other unreported unexpected events.  A total 
of 20 PCPs attended the Power Point presentation; however, only 12 completed and 
returned the pre/post surveys.   
Strengths 
Data from the surveys obtained the PCP perceptions of the educational power 
point presentation on the A1C education component monitoring according to the ADA 
practicing clinical guidelines.  All PCP answered the intent was to offer and provide 
effective, safe, and quality of care.  The group of PCPs answered 100% on the post 
survey that they were familiar with the ADA guidelines concerning the frequency of A1C 
monitoring of DM.  No PCP participants answered on either the pre and post survey as 
highly disagree.  See Appendix G for the differences in presurvey and postsurvey 
responses and Appendix H for the pre-post survey trends.   
The same number of people responded with highly disagree or somewhat 
disagree in the presurvey and in the postsurvey.  There were nine fewer responses of 
neither agree nor disagree and 13 fewer responses of somewhat agree in the postsurvey 
than in the presurvey.  There were 22 more responses of highly agreed with questions in 
the postsurvey than in the presurvey.  
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Summary 
The DNP project and PCP education in the Appalachian rural clinic is for 
sustainability as it used one of the most profound diseases in the nation today for the 
study.  PCP education on the monitoring of the A1C levels lead to help reduce 
comorbidities and mortality in the patient population. A presurvey, Power Point, and 
postsurvey was used as a tool in the data collection of 12 PCPs in the rural clinic.   
Data from the surveys obtained the PCP perceptions of the educational power 
point presentation on the A1C education component monitoring according to the ADA 
practicing clinical guidelines.  All PCP answered the intent was to offer and provide 
effective, safe, and quality of care.  100% answered on the postsurvey that they were 
familiar with the ADA guidelines concerning the frequency of A1C monitoring of DM.  
None of the PCP participants answered any question on either the pre or post survey as 
highly disagree.   
Total results indicate an overall improvement in total responses, the highly agree 
PCP presurvey total responses from all the question was 48%, with an increase on the 
PCP post survey to 68%.  PCP participation in the educational proponent for A1C 
monitoring and testing provided to be a beneficial outcome in the Appalachian rural 
clinic.  The increase in PCP knowledge of ADA clinical practice guidelines for A1C 
monitoring can only lead to improved patient outcomes and quality of care. 
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Section 5: Dissemination Plan 
Self-Analysis as a Scholar 
 The development of this DNP project has greatly increased my skills in 
implementing and developing a PCP education program using clinical scholarship and 
writing.  The dream of obtaining a terminal doctorate degree has been a goal of mine 
during most of my nursing career, first as a registered nurse and now as a nurse 
practitioner, which has spanned over 20+ years.  I will be able to reach my goal and 
dreams with the completion of this DNP project.  The role of the DNP has increased my 
awareness and importance of research of patient problems daily in clinical practice, 
especially scholarly articles.   
Self-Analysis as a Practitioner 
This DNP project has helped me to gain increased skills and knowledge as a 
family nurse practitioner and educator.  I have taught nursing in WV higher education in 
seat and online at private colleges, with plans to teach online nursing courses in the near 
future.  I have several years of experience in family practice and now work in the 
specialty area of palliative care and chronic illness.  Having a DNP degree leads to an 
augmented credibility to each of my roles in the future as an educator and currently in 
clinical practice.     
Self-Analysis as Project Developer 
 During the course of the development of this DNP project and PCP education, I 
have become passionate about researching topics in clinical practice.  The topics include 
not only DM but other chronic illness as well, in the patients I care for daily.  Working 
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many years in family practice and now in palliative care and chronic illness in the 
Appalachian region made me realize even more how important research can be.  Along 
with research, completion of the DNP project and doctoral degree have made me aware 
of the significance of keeping the PCP informed through education.  I feel more self-
confident and comfortable in the area of research and look forward to studies yet to come. 
The development of the DNP project and PCP education have given me more awareness 
and objectivity as well as the bonus of achieving my nursing dreams and goal.   
Summary 
 The evaluation of self as a scholar, practitioner, and project developer has been a 
timely and trying process, a journey I will not regret.  During this process, I have grown 
in all the areas in the evaluation of self.  In the area of scholar, there has been an increase 
in my skills in implementing and developing a PCP education program using clinical 
scholarship and writing.  In the process of all the years, my dream of obtaining a terminal 
doctorate degree is becoming reality.  In the area of practitioner, the DNP project has 
helped me increase skills and knowledge as a family nurse practitioner and educator.  As 
a DNP project developer, I am passionate about researching topics in clinical practice.  
Working many years in family practice and now in palliative care and chronic illness in 
the Appalachian region made me realize even more how important research can be.  The 
DNP project and doctoral degree made me feel more self-confident and comfortable in 
the area of research, and I look forward to studies yet to come.   
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Appendix A:  A1C Education Component  
Slide 1 
  A1C Education Component 
Quality Improvement & PCP Monitoring of A1C according to the American 
Diabetes Association Practice Guidelines 
  Susan Simmons MSN, FNP-C 
  Slide 2 
  A1C 
  The 2013 ADA Clinical Practice Guidelines for Medical Practice.   
  A1C monitoring and testing is considered to be “Gold Standard” in Diabetes 
Mellitus management and care. 
➢ Who? 
➢ Why? 
➢ When? 
   
  Slide 3  
  Who? 
  Why?  When? 
➢ Who?  The 2013 ADA Practice Guidelines and Standards of Care advises all DM 
patients be screened using A1C for management and treatment. 
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➢ Why?  Research and EBP determined that strict glucose control lessened the risk 
of associated complications from DM in renal, cardiovascular, ophthalmologic, 
and neurological systems. 
➢ When?  According to the ADA Practice Guidelines recommend that A1C 
monitoring and testing be done every 6 months (semi-annually) for patients that 
are stable with values < 7; every 4 months (quarterly) for patients A1C > 7; every 
3 months after a change in treatment for assessment of effectiveness of changed 
and/or new treatment. 
   
  Slide 4 
  Who? 
➢ General Patient Population – At risk for DM 
➢ DM Type I & II Adult (18 – 65) 
   
  Slide 5 
  Why? 
➢ Research study over a 10-year period performed by the NIH of over 1,440 
participants in the study with Type I DM.  The research study concluded that 
intensive glucose control decreases the risk of renal (50%), cardiovascular (57%), 
ophthalmologic (70%), and neurologic (60%) complications.   
➢ Research study over a 20-year period (1977-1997) performed by the UK 
Prospective DM study by Oxford University of over 5,000 participants.  The 
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research study concluded that intensive control over glucose decreases all 
microvascular diseases (24%); nonfatal CVA, MI (57%); Fatal MI (33%).   
   
  Slide 6 
  Why? 
➢ ≥Patients with an elevation of A1C levels have an increased risk for opportunistic 
disease and infection. 
➢ Keep in mind – if the A1C blood sugar ≥ 7%; the endothelial tissues of the renal, 
cardiovascular, ophthalmologic, and neurologic systems are under attack and 
higher risk for damage.   
   
  Slide 7 
  Why? 
➢ A1C of 7% = 154 Daily Average Blood Sugar ranges (123-185)  (ADA, 2010) 
➢ A1C of 8% = 183 Daily Average Blood Sugar ranges (147-217) (ADA, 2010) 
➢ A1C of 9% = 212 Daily Average Blood Sugar ranges (170-249) (ADA, 2010) 
   
  Slide 8 
  When? 
➢ PCP additional reasons to order A1C in the patient with DM 
➢ Non-Healing Wound 
➢ Vision Changes 
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➢ Fungal Infections (Candida) 
➢ Signs/Symptoms of Neuropathy 
➢ Recurrent UTI’s 
➢ Recurrent Sinusitis 
➢ Elevated BP 
➢ Fracture 
➢ Skin Infection (styes, boils, carbuncles, folliculitis, and, paronychia) 
   
  Slide 9 
  What? 
➢ What does this suggest for the patients? 
➢ End clinical inertia by having a current A1C  
➢ PCP recognize there is a problem with clinical inertia (failure to act) 
➢ PCP deliberately show a different behavior from the clinical inertia when 
unsure of their treatment options/choices, or does not know when a 
changed treatment is required and/or needed, or when questioning patient 
adherence to the recommended treatment options.   
 
 
 
 
 
  Slide 10 
  Ending Clinical Inertia 
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➢ Keep in Mind  
➢ Remember:   
➢ If the patients A1C is 7% = 154 Daily Average Blood Sugar ranges 
123-185.   
➢ If the patients A1C is 8% = 183 Daily Average Blood Sugar ranges 
147-217. 
➢ If the patients A1C is 9% = 212 Daily Average Blood Sugar ranges 
170-249.  
 
Slide 11 
A1C Tip Sheet 
➢ Patients with DM comes into the rural clinic 
➢ Is there an up to date or current A1C in the electronic health record? 
➢ If no current A1C, order and A1C. 
➢ If the patient A1C results is < 7%; order another A1C in 6 months. 
➢ If the patient A1C result is more than 7%; adjust DM regimen, then re-order in 3 
months. 
➢ If yes, and is <7%; the patient is therapeutic, re-order another A1C in 6 months.   
   
  Slide 12 
  Any Questions? 
  Thank you for being a participant! 
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  Slide 13 
  Reference 
American Diabetes Association (2013).  American Diabetes  Association standard 
of medical care practice guideline 2013.   Diabetes, 36 (Supp 1 S11-S66 doi:  
10,2337/dc13=S11  Retrieved from:  http://care.diabetes 
 journals.org/content/36/Supplement_1/S11.full. 
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Appendix B:  Pre/Post ADA Guidline (A1C) Study Test 
     Question 1- 9 Highly 
Disagree 
 
1 
Somewhat 
Disagree 
 
2 
Neither 
Agree, 
Nor 
Disagree 
3 
Somewhat 
Agree 
 
4 
Highly 
Agree 
 
5 
1.I am familiar with the 
American  
Diabetes Association 
(ADA) guidelines 
concerning the frequency 
of A1C testing in diabetes 
mellitus (DM) treatment 
and management. 
     
2. I personally offer safe, 
effective, and quality care.   
 
     
3. I personally like to use 
national clinical practice 
ADA guidelines to make 
treatment decisions.  
     
4. I personally believe the 
clinical practice ADA 
national guidelines are 
helpful when making 
treatment plans.  
     
5. I agree that having a 
current A1C is helpful in 
the development for 
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treatment decisions making 
for my DM patient 
population.  
6. I feel it is important to 
know a DM patient's A1C 
when I make treatment 
options.  
     
7. I feel in the future, 
utilizing a current A1C will 
be an integral part of my 
clinical treatment decisions.  
     
8. I follow the guidelines 
for frequency of assessing 
the A1C in patients with 
"unstable" DM? (A1C ≥ 
7%)   
  
 
  
9. I follow the frequency of 
assessing the A1C in 
patients with stable DM? 
(A1C ≤ 6.9) 
  
 
  
10. Describe any barriers that may exist in your clinical practice to measure A1C for 
your Type II DM patients.  
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Appendix C:  Primary Care Provider Pretest Survey Results 
Question Highly  
Disagree 
Somewhat 
Disagree 
Neither 
Agree Nor 
Disagree 
Somewhat 
Agree  
Highly 
Agree 
1.   1  11 
2.    2 10 
3.   2 4 6 
4.   1 7 4 
5.   1 5 6 
6.   1 4 7 
7.    8 4 
8.   4 5 3 
  2 3 6 1 
10.  Please use the space below to answer this question:  Describe any 
difficulties that occurred in your clinical practice to measure A1C for 
your DM Type 2 patients. Example: PCP non-adherence to guidelines 
is due to a cognitive difference of awareness, agreement, and adoption  
          
-  Distance the patient has to travel to be seen (rural setting) 
-  Delayed lab results (requiring extra follow-up appointment for 
patient) 
48 
 
 
 -  Lack of provider or nursing staff knowledge of guidelines 
-  Patient fails to keep appointment due to forgetfulness 
-  Bad weather or lack of transportation cause cancelled appointments 
-  Patients losing their lab order after A1C is ordered (lab location 
barrier) 
-  Patient simply doesn’t want to have blood drawn.  
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Appendix D:  Primary Care Provider Posttest Survey Results 
Question Highly  
Disagree 
Somewhat 
Disagree 
Neither 
Agree Nor 
Disagree 
Somewhat 
Agree  
Highly 
Agree 
1.     12 
2.     12 
3.    4 8 
4.    3 9 
5.    2 10 
6.   1 3 8 
7.    4 8 
8.   1 6 5 
9  2 2 6 2 
10.  Please use the space below to answer this question:  Describe any 
difficulties that occurred in your clinical practice to measure A1C for 
your DM Type 2 patients.    Example: PCP non-adherence to 
guidelines is due to a cognitive difference of awareness, agreement, 
and adoption          
              
-  Distance the patient has to travel to be seen (rural setting) 
-  Delayed lab results (requiring extra follow-up appointment for 
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patient) 
-  Patient fails to keep appointment due to forgetfulness 
-  Bad weather or lack of transportation cause cancelled appointments 
-  Patients losing their lab order after A1C is ordered (lab location 
barrier) 
-  Patient is non-compliant or patient knows that A1C will be elevated 
-  Patient simply doesn’t want to have blood drawn.   
-  Patient doesn’t want to come to appointment because it might result 
in added medications or a change in their lifestyle.   
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Appendix E:  Pie Chart for Comparison of Presurvey of Total Responses 
 
Pie Chart for Comparison of Presurvey of Total Responses 
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 Appendix F:  Pie Chart for Comparison of Postsurvey of Total Responses  
 
Pie Chart for Comparison of Postsurvey of Total Responses 
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 Appendix G: Difference in Presurvey and Postsurvey Responses 
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Appendix H:  Pre/Post PCP Survey Trends Indicate an Improvement Post Survey 
 
 
